Department of Molecular Biology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
Department of Transplant Immunology and Applied Microbiology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
J Infect Dev Ctries. 2021 Oct 31;15(10):1376-1383. doi: 10.3855/jidc.14900.
The first case of severe acute respiratory syndrome 2 (SARS-CoV-2) was imported to Pakistan in February 2020, since then 8,260 deaths have been witnessed. The virus has been constantly mutating and local transmission cases from different countries vary due to host dependent viral adaptation. Many distinct clusters of variant SARS-CoV-2 have been defined globally. In this study, the epidemiology of SARS-CoV-2 was studied and locally transmitted SARS-CoV-2 isolates from Karachi were sequenced to compared and identify any possible variants.
The real time PCR was performed on nasopharyngeal specimen to confirm SARS-CoV-2 with Orf 1ab and E gene as targets. The virus isolates were sequenced through oxford nanopore technology MinION platform. Isolates from the first and second wave of COVID-19 outbreak in Karachi were compared.
The overall positivity rate for PCR was 26.24% with the highest number of positive cases in June. Approximately, 37.45% PCR positive subjects aged between 19-40 years. All the isolates belonged to GH clade and shared missense mutation D614G in spike protein linked to increased transmission rate worldwide. Another spike protein mutation A222V coexisted with D614G in the virus from the second wave of COVID-19.
Based on the present findings it is suggested that the locally transmitted virus from Karachi varies from those reported from other parts of Pakistan. Slight variability was also observed between viruses from the first and second wave. Variability in any potential vaccine target may result in failed trials, therefore information on any local viral variants is always useful for effective vaccine design and/or selection.
2020 年 2 月,首例严重急性呼吸综合征 2(SARS-CoV-2)病例输入巴基斯坦,自此已见证 8260 例死亡。该病毒不断变异,由于宿主依赖性病毒适应,来自不同国家的本地传播病例各不相同。全球已定义了许多不同的 SARS-CoV-2 变体簇。在这项研究中,研究了 SARS-CoV-2 的流行病学,并对卡拉奇的本地传播 SARS-CoV-2 分离株进行了测序,以比较和识别任何可能的变体。
使用实时 PCR 以 Orf 1ab 和 E 基因作为靶标,对鼻咽标本进行 SARS-CoV-2 确认。通过牛津纳米孔技术 MinION 平台对病毒分离物进行测序。比较了卡拉奇 COVID-19 爆发第一波和第二波的分离物。
PCR 的总体阳性率为 26.24%,6 月阳性病例最多。大约 37.45%的 PCR 阳性患者年龄在 19-40 岁之间。所有分离物均属于 GH 分支,在刺突蛋白中共享与全球传播率增加相关的错义突变 D614G。第二个 COVID-19 波中病毒的刺突蛋白突变 A222V 与 D614G 共存。
根据目前的发现,建议从卡拉奇本地传播的病毒与从巴基斯坦其他地区报告的病毒不同。第一波和第二波病毒之间也观察到轻微的变异性。任何潜在疫苗靶标的变异性都可能导致试验失败,因此有关任何本地病毒变体的信息对于有效的疫苗设计和/或选择总是有用的。